|
Fetal origins of stress-related adult disease |
E. Kajantie |
|
Birth-weight, stress in childhood, and the metabolic syndrome in adult life |
D. Phillips |
|
Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? |
E. Charmandari and G.P. Chrousos |
|
Stress in women: metabolic syndrome and the PCOS |
E. Diamanti-Kandarakis and F. Economou |
|
Stress, the endoplasmic reticulum and insulin resistance |
P. Tsiotra and C. Tsigos |
|
Stress, visceral obesity and metabolic complications |
I. Kyrou, G.P. Chrousos, and C. Tsigos |
|
The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome |
R. Pasquali ... [et al.] |
|
Sympathetic system activity in obesity and the metabolic syndrome |
N. Tendolouris, S. Liatis, and N. Katsilambros |
|
Glucocorticoid receptor variants and obesity risk |
R. Rosmond, V. Radulovic, and G. Holm |
|
Tissue production of cortisol by 11[beta]-hydroxysteroid dehydrogenase type 1 and metabolic risks |
B.R. Walker and R. Andrew |
|
Peripheral factors in the metabolic syndrome: the pivotal role of adiponectin |
C. Tsatsanis ... [et al.] |
|
The protective role of exercise on stress system dysregulation and co-morbidities |
A. Tsatsoulis |
|
Nutrition and inflammatory load |
M.D. Kontogianni, A. Zambelas, and C. Tsigos |
|
Potential uses of CRH antagonists |
A. Zoumakis and G. P. Chrousos |
|
Serotonin and norepinephrine reuptake inhibition and eating behavior |
V. Hainer ... [et al.] |
|
Targeting the cannabinoid system in obesity and metabolic syndrome |
C. Tsigos and I. Kyrou |
|
Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome proliferator activated receptors |
V.D. Yumuk |
|
Fetal origins of stress-related adult disease |
E. Kajantie |
|
Birth-weight, stress in childhood, and the metabolic syndrome in adult life |
D. Phillips |
|
Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? |
E. Charmandari and G.P. Chrousos |